Pilot Study of New Computer-based Neuropsychological Tool: Visual Tests, Touch Responses

NYU Langone Health1 site in 1 country137 target enrollmentMay 10, 2019

ConditionsCerebral Neurological Illness

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Cerebral Neurological Illness
Sponsor: NYU Langone Health
Enrollment: 137
Locations: 1
Primary Endpoint: Score on Railroad Test
Status: Completed
Last Updated: last year

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

This study is aimed at investigating three new tests that will form part of a computerized tool designed to test brain/cognitive functioning. The system will be evaluated along with the tests' usability on samples of healthy controls and neurologically impaired patient participants. These new tests will be assessed with regard to reliability and validity. Reliability will be addressed through investigation of internal consistency of the test items. Validity will be evaluated relative to traditional paper-and-pencil tests and differentiation between patient and healthy participants.Each participant will complete both the computerized and paper and pencil-based tests. The results will be analyzed to see how performances on the two test types compare. The overall aim of this project is to determine if these new computerized tasks are an improvement over standard paper and pencil-based neuropsychological measures.

Registry

clinicaltrials.gov

Start Date

May 10, 2019

End Date

December 6, 2023

Last Updated

last year

Study Type

Interventional

Study Design

Parallel

Sex

All

Investigators

Sponsor

NYU Langone Health

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Individuals without positive cerebral findings on neuroimaging (Non-PCF)
•Participants can be male or female and between the ages of 21 and 65 years old.
•Participants will have adequate perceptual and motor capabilities to participate in testing.
•Neuroimaging-positive cerebral findings (PCF)
•Patients at NYULMC identified to have significant cerebral findings on neuroimaging.
•Participants will be male or female and between the ages of 21 and 65 years old.
•Participants will have adequate perceptual and motor capabilities to participate in testing.

Exclusion Criteria

•Participants without adequate perceptual and motor capacities preventing them from participation in the testing.
•Participants with severe dysfunction at the level of dementia that can interfere with informed consent.